Baxter Q3 Results Lift Outlook but Shares Fall After EPS Dip
Baxter reported Q3 revenue of almost $3bn, up 5%, and raised its 2026 earnings outlook, but shares fell more than 4% aft…
Read full reportSale on Ophthalmic Equipment - Starting from 16 November!
News tagged “MedicalDevices”.
Baxter reported Q3 revenue of almost $3bn, up 5%, and raised its 2026 earnings outlook, but shares fell more than 4% aft…
Elixir White 72 views
Universal Health Services reports a 17% decline in net income in Q3 2026, driven by lower surgical volumes, losses at ne…
Read more
SetPoint Medical is treating its first Boston patient with an FDA-approved neuroimmune modulation system, an implantable…
Read more
The BMA criticises limited NHS investment in the UK Autumn Budget 2026, despite £290m allocated to winter pressures and …
Read more
Empatica launches WellPD, an FDA-cleared and CE-marked Parkinson’s wearable that monitors motor symptoms, sleep and acti…
Read more
GE HealthCare raises its 2026 earnings outlook after reporting $5.5bn in Q3 revenue, driven by strong pharmaceutical dia…
Read more
CVS Health has sued the federal government over its 2027 Medicare Advantage star ratings, challenging 28 measures and ci…
Read more
Boston Scientific has lowered its 2026 sales and earnings forecasts for the third time this year after a weak third quar…
Read more
The FDA has granted breakthrough device designation to Pharaoh Neuro Neurapheresis, a closed loop CSF management system …
Read more
Bionix has launched ReadyHub, a procedure-staging system that extends its OneLight line from illumination to room prepar…
Read more
The FDA has cleared Deep Reasoning AI NeuroDR, software that builds 3D views of head and neck arteries from CT angiograp…
Read more
CEOs from Medtronic, Stryker, Boston Scientific, Insulet and Mass General Brigham spoke at the Boston MedTech Conference…
Read more
New UCL led OPTIMA analysis, presented at ESMO 2026, suggests wider use of Veracyte’s Prosigna test could save the NHS u…
Read more